How many institutions held KTTA - Pasithea Therapeutics Corp. - Common Stock, par value $0.0001 in Q1 2024?

6 institutional investors reported KTTA - Pasithea Therapeutics Corp. - Common Stock, par value $0.0001 for Q1 2024. Use the holders table for investor-level position and value details.

Pasithea Therapeutics Corp. - Common Stock, par value $0.0001 (KTTA)

Q: What does CUSIP 70261F202 represent in this 13F holders report?

CUSIP 70261F202 is the security identifier for KTTA - Pasithea Therapeutics Corp. - Common Stock, par value $0.0001 used to aggregate holder disclosures.

CUSIP: 70261F202

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class: Equity / Common Stock, par value $0.0001
Shares outstanding: 24,858,270
Total 13F shares: 30,055
Share change: +30,055
Total reported value: $218,102
Price per share: $7.28
Number of holders: 6
Value change: +$218,102
Number of buys: 6

Quarterly Holders Quick Answers

What is CUSIP 70261F202?
CUSIP 70261F202 identifies KTTA - Pasithea Therapeutics Corp. - Common Stock, par value $0.0001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2024

Recent filing periods for CUSIP 70261F202:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of KTTA - Pasithea Therapeutics Corp. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PD Joint Holdings, LLC Series 2016-A	3/4/5	10%+ Owner	— class O/S missing	2,608,696	$1,124,348	—	22 Oct 2022	3/4/5
Eric Shahinian	3/4/5	Member of 10% owner group	— class O/S missing	1,788,415	$770,807	—	28 Sep 2022	3/4/5
Israel Maxx Abramowitz	3/4/5	Not a 10% owner	— class O/S missing	1,051,575	$453,229	—	14 Sep 2021	3/4/5
Dean Lazer	3/4/5	Not a 10% owner	— class O/S missing	902,600	$389,021	—	14 Sep 2021	3/4/5
Eric Lazer	3/4/5	Not a 10% owner	— class O/S missing	902,600	$389,021	—	14 Sep 2021	3/4/5
Dr. Yassine Bendiabdallah	3/4/5	Chief Operating Officer, Director	— class O/S missing	300,000	$129,300	—	14 Sep 2021	3/4/5
David Delaney	3/4/5	Member of 10% owner group	— class O/S missing	227,521	$98,062	—	17 Oct 2022	3/4/5
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	125,123	$48,824	—	31 Dec 2023	13F
Avi Geller	3/4/5	Member of 10% owner group	— class O/S missing	54,644	$23,552	—	19 Aug 2022	3/4/5
ARMISTICE CAPITAL, LLC	13F	Company	— class O/S missing	1,000,000	$18,000	—	31 Dec 2023	13F
NORTHERN TRUST CORP	13F	Company	— class O/S missing	47,074	$17,417	—	31 Dec 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	— class O/S missing	32,500	$12,000	—	31 Dec 2023	13F
JANE STREET GROUP, LLC	13F	Company	— class O/S missing	23,588	$8,728	—	31 Dec 2023	13F
Kepos Capital LP	13F	Company	— class O/S missing	334,600	$6,000	—	31 Dec 2023	13F
Warberg Asset Management LLC	13F	Company	— class O/S missing	289,868	$5,218	—	31 Dec 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	— class O/S missing	12,396	$4,587	—	31 Dec 2023	13F
ROYAL BANK OF CANADA	13F	Company	— class O/S missing	5,000	$2,000	—	31 Dec 2023	13F
JPMORGAN CHASE & CO	13F	Company	— class O/S missing	3,000	$1,110	—	31 Dec 2023	13F
Marex Group plc	13F	Company	— class O/S missing	25,000	$450	—	31 Dec 2023	13F
CITADEL ADVISORS LLC	13F	Company	— class O/S missing	13,104	$236	—	31 Dec 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	— class O/S missing	127	$47	—	31 Dec 2023	13F
Graeme Martin Currie	3/4/5	Chief Development Officer	— class O/S missing	5,938	—	—	01 Mar 2024	3/4/5

Institutional Holders of Pasithea Therapeutics Corp. - Common Stock, par value $0.0001 (KTTA) as of Q1 2024

As of 31 Mar 2024, Pasithea Therapeutics Corp. - Common Stock, par value $0.0001 (KTTA) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,055 shares. The largest 6 holders included ADAR1 Capital Management, LLC, Tower Research Capital LLC (TRC), UBS Group AG, Royal Bank of Canada, JPMORGAN CHASE & CO, and WELLS FARGO & COMPANY/MN. This page lists 6 institutional shareholders reporting positions in this security for the Q1 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2024 vs Q4 2025 Across Filers

Q4 2025 holders

Q1 2024 holders

Holder diff

-18

Investor	Q4 2025 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.